Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Thyroid Carcinoma, Anaplastic × Hydroxyurea × Clear all

Sponsor

Conditions

Brain Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Meningioma 3 Glioblastoma 3 Polycythemia Vera 2 Neoplasms 2 Leukemia, Myeloid, Acute 2 Head and Neck Neoplasms 2 Gliosarcoma 2 Thrombocytosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pharyngeal Neoplasms 1 Paranasal Sinus Neoplasms 1 Papillomavirus Infections 1 Nose Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Lymphoma, Non-Hodgkin 1 Laryngeal Neoplasms 1 Hodgkin Disease 1 Glioma 1 Epstein-Barr Virus Infections 1 Carcinoma, Squamous Cell 1 Carcinoma 1

Interventions

Paclitaxel 3 pembrolizumab 2 efatutazone 2 trametinib 1 tislelizumab 1 surufatinib 1 spartalizumab 1 sapanisertib 1 pazopanib 1 lenvatinib 1 fosbretabulin 1 dabrafenib 1 crolibulin 1 combretastatin 1 cabozantinib 1 atezolizumab 1 abemaciclib 1 Sorafenib 1 Radiotherapy, Intensity-Modulated 1 Imatinib Mesylate 1 Gefitinib 1 Doxorubicin 1 Docetaxel 1 Cisplatin 1 Carboplatin 1 CUDC-907 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡